Palvella Therapeutics Inc (PVLA)
25.67 x 2 32.18 x 1
Post-market by (Cboe BZX)
27.43 -0.18 (-0.65%) 03/20/25 [NASDAQ]
25.67 x 2 32.18 x 1
Post-market 27.43 unch (unch) 16:00 ET
for Thu, Mar 20th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,396 | 38,635 | 117,764 | 70,436 | 62,260 |
| Marketable Securities | 8,970 | 20,534 | N/A | N/A | 41,894 |
| Receivables | 6,039 | 11,043 | 3,313 | 1,706 | 6,787 |
| Other current assets | 2,188 | 0 | 0 | 0 | 0 |
| TOTAL | $38,680 | $73,424 | $127,625 | $75,721 | $115,013 |
| Non-Current Assets | |||||
| PPE Net | N/A | 16,992 | 19,122 | 22,046 | 19,502 |
| Other Non-Current Assets | 0 | 5,074 | 6,813 | 7,243 | 6,582 |
| TOTAL | $N/A | $22,066 | $25,935 | $29,289 | $26,084 |
| Total Assets | $38,680 | $95,490 | $153,560 | $105,010 | $141,097 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,372 | 4,154 | 8,609 | 1,787 | 5,803 |
| Accrued Expenses | 8,550 | 10,746 | 16,836 | 7,731 | 9,944 |
| TOTAL | $11,922 | $36,583 | $50,561 | $22,145 | $27,003 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 20,824 | 25,116 | 12,627 | 11,256 |
| aiOther Non-Current Liabilities | 0 | 12,244 | 13,841 | 15,938 | 15,484 |
| TOTAL | $N/A | $30,978 | $52,244 | $51,838 | $62,742 |
| Total Liabilities | $11,922 | $67,561 | $102,805 | $73,983 | $89,745 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,237 | 931 | 926 | 746 | 690 |
| Common Shares | 98 | 74 | 72 | 56 | 55 |
| Retained earnings | -314,964 | -290,421 | -257,144 | -211,406 | -174,176 |
| Other shareholders' equity | 28 | -254 | 829 | -295 | -1,995 |
| TOTAL | $26,758 | $27,929 | $50,755 | $31,027 | $51,352 |
| Total Liabilities And Equity | $38,680 | $95,490 | $153,560 | $105,010 | $141,097 |